| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
B (NF-
B) in Human Diploid Fibroblasts1
Lineberger Comprehensive Cancer Center [B. P. A., A. S. B.], Department of Biology and Curriculum in Genetics and Molecular Biology [A. S. B.], University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, and National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709 [R. E. S., R. S. P.]
It has been suggested that the cellular response to exposure to ionizing radiation involves activation of the transcription factor nuclear factor-
B (NF-
B) and that this response is defective in cells from individuals with ataxia telangiectasia (AT). In one study, it was found that SV40 large T-transformed cells derived from a patient null for the AT mutated (ATM) gene exhibited constitutive activation of NF-
B and that in those cells, inhibition of NF-
B by expression of a modified form of I
B
led to correction of the radiosensitivity associated with the AT phenotype [M. Jung et al., Science (Washington DC), 268: 16911621, 1995]. From those data, it was suggested that NF-
B played a role in the AT phenotype. We show here that normal diploid cells derived from AT patients do not exhibit constitutive activation of NF-
B. Furthermore, we provide data that the transformation process associated with SV40 large T antigen expression in AT-/- cells leads to aberrant cellular responses. Our studies highlight the importance of using diploid, nontransformed AT-/- cells for in vitro studies relevant to the AT phenotype whenever possible.
This article has been cited by other articles:
![]() |
P. Javvadi, A. T. Segan, S. W. Tuttle, and C. Koumenis The Chemopreventive Agent Curcumin Is a Potent Radiosensitizer of Human Cervical Tumor Cells via Increased Reactive Oxygen Species Production and Overactivation of the Mitogen-Activated Protein Kinase Pathway Mol. Pharmacol., May 1, 2008; 73(5): 1491 - 1501. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Starenki, H. Namba, V. Saenko, A. Ohtsuru, and S. Yamashita Inhibition of Nuclear Factor-{kappa}B Cascade Potentiates the Effect of a Combination Treatment of Anaplastic Thyroid Cancer Cells J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 410 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Ashburner, S. D. Westerheide, and A. S. Baldwin Jr. The p65 (RelA) Subunit of NF-{kappa}B Interacts with the Histone Deacetylase (HDAC) Corepressors HDAC1 and HDAC2 To Negatively Regulate Gene Expression Mol. Cell. Biol., October 15, 2001; 21(20): 7065 - 7077. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Abraham Cell cycle checkpoint signaling through the ATM and ATR kinases Genes & Dev., September 1, 2001; 15(17): 2177 - 2196. [Full Text] [PDF] |
||||
![]() |
F. Chen, V. Castranova, and X. Shi New Insights into the Role of Nuclear Factor-{kappa}B in Cell Growth Regulation Am. J. Pathol., August 1, 2001; 159(2): 387 - 397. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |